Literature DB >> 22609407

CK2 regulates ATF4 and CHOP transcription within the cellular stress response signalling pathway.

Carolin C Schneider1, Emmanuel Ampofo, Mathias Montenarh.   

Abstract

Protein kinase CK2 is an ubiquitously expressed serine/threonine kinase. The protein levels along with CK2 activity are highly elevated in tumour cells where it protects cells from apoptosis. Accordingly, inhibition of CK2 is known to induce programmed cell death, making it a promising target for cancer therapy. Analysis of the different behaviour of hormone sensitive LNCaP cells and hormone refractory PC-3 cells after CK2 inhibition revealed CHOP ((C/EBP)-homologous protein) induction and therefore probably ER stress as crucial for apoptosis in the LNCaP cells. In the present study we investigated which promoter element of the CHOP promoter is responsible for its induction. ER stress can be generated by the accumulation of unfolded proteins, by depletion of amino acids or by oxidative stress. ER stress induces specific signalling pathways. In order to analyse which pathway might be activated by CK2 inhibition we started to analyse the activation of the different CHOP promoter elements. By using mutated reporter constructs of the CHOP promoter, it turned out that the amino acid response element (AARE) is the most prominent element for CHOP induction after CK2 inhibition. The ER stress element, however, proves to be less crucial, and along with the AP-1 binding site, they do not seem to play any role. Further we found an up-regulation of the transcription factor ATF4 after CK2 inhibition. ATF4 is involved in ER stress signalling through the AARE, which further supports our finding that CK2 inhibition provokes an amino acid induced response pathway.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609407     DOI: 10.1016/j.cellsig.2012.05.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling.

Authors:  F Buontempo; E Orsini; L R Martins; I Antunes; A Lonetti; F Chiarini; G Tabellini; C Evangelisti; C Evangelisti; F Melchionda; A Pession; A Bertaina; F Locatelli; J A McCubrey; A Cappellini; J T Barata; A M Martelli
Journal:  Leukemia       Date:  2013-11-20       Impact factor: 11.528

2.  Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer.

Authors:  Tina Horbach; Claudia Götz; Thomas Kietzmann; Elitsa Y Dimova
Journal:  Front Pharmacol       Date:  2015-02-18       Impact factor: 5.810

3.  Functional interplay between the transcription factors USF1 and PDX-1 and protein kinase CK2 in pancreatic β-cells.

Authors:  Sarah Spohrer; Rebecca Groß; Lisa Nalbach; Lisa Schwind; Heike Stumpf; Michael D Menger; Emmanuel Ampofo; Mathias Montenarh; Claudia Götz
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

Review 4.  Therapeutic targeting of CK2 in acute and chronic leukemias.

Authors:  F Buontempo; J A McCubrey; E Orsini; M Ruzzene; A Cappellini; A Lonetti; C Evangelisti; F Chiarini; C Evangelisti; J T Barata; A M Martelli
Journal:  Leukemia       Date:  2017-09-27       Impact factor: 11.528

5.  CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression.

Authors:  Janeen H Trembley; Betsy T Kren; Md J Abedin; Daniel P Shaughnessy; Yingming Li; Scott M Dehm; Khalil Ahmed
Journal:  Pharmaceuticals (Basel)       Date:  2019-06-14

Review 6.  Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2.

Authors:  Zaira Spinello; Anna Fregnani; Laura Quotti Tubi; Livio Trentin; Francesco Piazza; Sabrina Manni
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

7.  Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells.

Authors:  Sabrina Manni; Alessandra Brancalion; Elisa Mandato; Laura Quotti Tubi; Anna Colpo; Marco Pizzi; Rocco Cappellesso; Fortunato Zaffino; Speranza Antonia Di Maggio; Anna Cabrelle; Filippo Marino; Renato Zambello; Livio Trentin; Fausto Adami; Carmela Gurrieri; Gianpietro Semenzato; Francesco Piazza
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

Review 8.  Protein Kinase CK2-A Putative Target for the Therapy of Diabetes Mellitus?

Authors:  Emmanuel Ampofo; Lisa Nalbach; Michael D Menger; Mathias Montenarh; Claudia Götz
Journal:  Int J Mol Sci       Date:  2019-09-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.